Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lipid lowering therapy: new pathophysiologic aspects and clinical implications]

A Nordmann1, B Martina, U Keller

  • 1Medizinische Universitäts-Poliklinik, Kantonsspital Basel.

Schweizerische Medizinische Wochenschrift
|June 12, 1998
PubMed
Summary

Lipid-lowering therapy offers cardiovascular benefits beyond plaque size reduction. It improves endothelial function and other factors, contributing to reduced cardiovascular risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of antiviral, immunomodulatory and platelet-enhancing agents for treatment of dengue infection: A systematic review.

Virulence·2025
Same author

The role of antibody-dependent enhancement in dengue vaccination.

Tropical diseases, travel medicine and vaccines·2024
Same author

Competences of internal medicine specialists for the management of patients with multimorbidity. EFIM multimorbidity working group position paper.

European journal of internal medicine·2023
Same author

Depressive symptoms, but not anxiety, predict subsequent diagnosis of Coronavirus disease 19: a national cohort study.

Epidemiology and psychiatric sciences·2022
Same author

Perspectives of European internists on multimorbidity. A multinational survey.

European journal of internal medicine·2022
Same author

Parallel processing in human visual cortex revealed through the influence of their neural responses on the visual evoked potential.

Vision research·2022

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Context:

  • Lipid-lowering therapy is crucial for reducing cardiovascular morbidity and mortality.
  • While plaque regression is observed, it doesn't fully account for clinical benefits.

Purpose:

  • To explore mechanisms of lipid-lowering therapy beyond plaque size reduction.
  • To highlight the role of endothelial function in cardiovascular disease.

Summary:

  • Lipid-lowering therapy induces qualitative plaque composition changes, potentially reducing rupture risk.
  • It reverses endothelial dysfunction, improving vasodilation and reducing adhesion molecules.
  • Therapy may also decrease peripheral resistance, hyperinsulinemia, and improve erythrocyte deformability.

Impact:

Related Experiment Videos

  • Endothelial dysfunction is an early, reversible sign of target organ damage.
  • Understanding these mechanisms can refine cardiovascular disease diagnosis and treatment.
  • These findings emphasize a broader therapeutic impact of lipid management.